Form 4: Director Fred Zeidman Increases Stake in Bluejay Diagnostics

Director Fred S. Zeidman acquired 12,500 shares of Bluejay Diagnostics, Inc. common stock in a private placement transaction.

Summary

• Director Fred S. Zeidman purchased 12,500 shares of common stock on March 14, 2026.
• The shares were acquired directly from the issuer in a private placement.
• The purchase price was $2.00 per share, totaling an investment of $25,000.
• Following this transaction, Mr. Zeidman holds 12,500 shares of the company.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically indicates confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by a director purchasing shares directly from the company.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal of management's belief in the company's long-term valuation, particularly when occurring via private placement directly with the issuer.

Comparison to Industry Standards

• Insider purchases are standard corporate governance signals used to align director interests with shareholders.

Related Party Transactions

• The director purchased shares directly from the issuer in a private placement.

Stakeholder Impact

• Shareholders may view the director's capital commitment as a sign of stability and confidence.

Next Steps

• No further actions or milestones were disclosed in this filing.

Key Dates

Keywords

Bluejay Diagnostics, BJDX, Insider Trading, Form 4, Director Purchase